Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Androgenetic alopecia is a common hair thinning condition linked to genetics and hormones.

Stem cells preservation in AGA could be a potential therapy, but more cases needed.

Hair loss in women can be caused by genetics, menopause, certain health conditions, and emotional stress, and it often results in thinner hair and a changing hairline.

Proper medical treatments can control and even reverse female pattern hair loss, but it's important to check for related conditions like excessive male hormone production, especially in severe cases.

Hair loss is due to thinner hairs, not less hairs; hair diameter indicates balding progression and treatment effectiveness.

AGA is a common hair loss affecting both genders, treated with various therapies to promote regrowth and slow thinning.

Hair loss in women, often not related to male hormones, increases with age and can cause significant emotional distress.

Male androgenetic alopecia (MAA) is a common, hereditary hair loss condition in men, linked to heart disease, and can be treated with minoxidil, finasteride, or hair transplantation.

Hair loss and aging are caused by the breakdown of a key protein in hair stem cells.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

Careful planning and patient counseling can lead to excellent hair transplant results, often in one or two sessions.

High levels of testosterone and 5α-DHT can lead to cell death in cells important for hair growth.

Wnt10b makes hair follicles bigger, but DKK1 can reverse this effect.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

The protein ARA70/ELE1 is involved in male pattern baldness, and lower levels of its short form may lead to hair thinning.

A gene mutation causes woolly hair in a Syrian patient.

Microinflammation is more intense in smaller hair follicles and may be linked to hair loss.

Hair stem cells produce a protein called COL17A1 that plays a key role in their development and is linked to hair thinning and baldness.

Low-dose oral minoxidil effectively reduces hair loss in women with female pattern hair loss.

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

UV exposure causes hair thinning, graying, and changes in hair growth cycles in mice.

Intense pulsed light treatment effectively reduces underarm hair by making hair follicles smaller and extending their resting phase.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

Sebaceous glands are involved in various skin disorders, some treatable with medications like finasteride and minoxidil.

Male pattern baldness is linked to higher levels of a certain receptor in the scalp, which leads to the shrinking of blood vessels and hair loss. Early treatment targeting this receptor could be more effective.

Inhibiting Zyxin may help treat androgenetic alopecia by promoting hair growth.